Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET
暂无分享,去创建一个
N. Costes | J. Redouté | D. Le Bars | P. Boulinguez | B. Ballanger | I. Mérida | Sophie Lancelot | C. Laurencin
[1] N. Costes,et al. Modeling [11C]yohimbine PET human brain kinetics with test-retest reliability, competition sensitivity studies and search for a suitable reference region , 2021, NeuroImage.
[2] C. Cavada,et al. Distribution of the Noradrenaline Innervation and Adrenoceptors in the Macaque Monkey Thalamus , 2021, Cerebral cortex.
[3] T. Robbins,et al. The role of noradrenaline in cognition and cognitive disorders , 2021, Brain : a journal of neurology.
[4] G. Miller,et al. Restoration of Noradrenergic Function in Parkinson’s Disease Model Mice , 2021, ASN neuro.
[5] Sarika Singh. Noradrenergic pathways of locus coeruleus in Parkinson’s and Alzheimer’s pathology , 2020, The International journal of neuroscience.
[6] F. Drago,et al. Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia Activation , 2019, Front. Pharmacol..
[7] Anthonin Reilhac,et al. Development of a Dedicated Rebinner with Rigid Motion Correction for the mMR PET/MR Scanner, and Validation in a Large Cohort of 11C-PIB Scans , 2018, The Journal of Nuclear Medicine.
[8] A. Harkin,et al. Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease. , 2018, Neural regeneration research.
[9] D. Weinshenker. Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease , 2018, Trends in Neurosciences.
[10] N. Costes,et al. Multi-atlas attenuation correction supports full quantification of static and dynamic brain PET data in PET-MR , 2017, Physics in medicine and biology.
[11] A. Gjedde,et al. Mapping α2 Adrenoceptors of the Human Brain with 11C-Yohimbine , 2015, Journal of Nuclear Medicine.
[12] A. Björklund,et al. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease , 2014, Experimental Neurology.
[13] N. Raz,et al. Prefrontal cortex and executive functions in healthy adults: A meta-analysis of structural neuroimaging studies , 2014, Neuroscience & Biobehavioral Reviews.
[14] D. Nutt,et al. Noradrenaline – the forgotten amine? , 2013 .
[15] E. Szabadi. Functional neuroanatomy of the central noradrenergic system , 2013, Journal of psychopharmacology.
[16] S. Sara,et al. Orienting and Reorienting: The Locus Coeruleus Mediates Cognition through Arousal , 2012, Neuron.
[17] A. Landau,et al. Amphetamine challenge decreases yohimbine binding to α2 adrenoceptors in Landrace pig brain , 2012, Psychopharmacology.
[18] Abdelhamid Benazzouz,et al. Noradrenaline and Parkinson's Disease , 2011, Front. Syst. Neurosci..
[19] Daniel Rueckert,et al. Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation , 2010, NeuroImage.
[20] J. Tiihonen,et al. Autoradiographic characterization of α2C‐adrenoceptors in the human striatum , 2008, Synapse.
[21] F. Fornai,et al. Noradrenaline in Parkinson's disease: from disease progression to current therapeutics. , 2007, Current medicinal chemistry.
[22] J. Roth,et al. α2A‐Adrenoceptors Regulate Sympathetic Transmitter Release in Mice Kidneys , 2007, British journal of pharmacology.
[23] Donald F. Smith,et al. Detection of α2-Adrenergic Receptors in Brain of Living Pig with 11C-Yohimbine , 2006 .
[24] Daniel Rueckert,et al. Automatic anatomical brain MRI segmentation combining label propagation and decision fusion , 2006, NeuroImage.
[25] D Yves von Cramon,et al. Decision-making and the frontal lobes , 2006, Current opinion in neurology.
[26] Jonathan D. Cohen,et al. Adaptive gain and the role of the locus coeruleus–norepinephrine system in optimal performance , 2005, The Journal of comparative neurology.
[27] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[28] A. Rosenquist,et al. Noradrenergic mechanisms in neurodegenerative diseases: a theory , 2004, Brain Research Reviews.
[29] E. Rolls. The functions of the orbitofrontal cortex , 1999, Brain and Cognition.
[30] Alexander Hammers,et al. Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.
[31] C. Berridge,et al. The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.
[32] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[33] Joshua W. Brown,et al. Monitoring and Control of Action by the Frontal Lobes , 2002, Neuron.
[34] L. Hein,et al. Two α2-adrenergic receptor subtypes, α2A and α2C, inhibit transmitter release in the brain of gene-targeted mice , 2002, Neuroscience.
[35] Morris Freedman,et al. Frontal lobe functions , 2001, Current neurology and neuroscience reports.
[36] M. Weissman,et al. Ethnic and sex differences in suicide rates relative to major depression in the United States. , 2001, The American journal of psychiatry.
[37] K. Starke,et al. α2‐Adrenoceptors modulating neuronal serotonin release: a study in α2‐adrenoceptor subtype‐deficient mice , 2001 .
[38] B. Kobilka,et al. Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission , 1999, Nature.
[39] T. Reader,et al. Regional brain distribution of noradrenaline uptake sites, and of α1-, α2- and β-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study , 1999, Neuroscience.
[40] D. Bernstein,et al. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. , 1999, Molecular pharmacology.
[41] D. Bylund. Pharmacological Characteristics of Alpha‐2 Adrenergic Receptor Subtypes , 1995, Annals of the New York Academy of Sciences.
[42] Á. Pazos,et al. Autoradiographic Demonstration of Increased α2‐Adrenoceptor Agonist Binding Sites in the Hippocampus and Frontal Cortex of Depressed Suicide Victims , 1994, Journal of neurochemistry.
[43] A. M. Etgen,et al. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype. , 1994, Molecular pharmacology.
[44] R. Kessler,et al. Panic and panic disorder in the United States. , 1994, The American journal of psychiatry.
[45] D. Heal,et al. Quantification of presynaptic α2-adrenoceptors in rat brain after short-term DSP-4 lesioning , 1993 .
[46] M. Sastre,et al. Opposite Age‐Dependent Changes of α2A‐Adrenoceptors and Nonadrenoceptor [3H]Idazoxan Binding Sites (I2‐Imidazoline Sites) in the Human Brain: Strong Correlation of I2 with Monoamine Oxidase‐B Sites , 1993, Journal of neurochemistry.
[47] A. M. Etgen,et al. Estradiol attenuates alpha 2-adrenoceptor-mediated inhibition of hypothalamic norepinephrine release , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] G. Ordway,et al. Characterization of subtypes of alpha-2 adrenoceptors in the human brain. , 1993, The Journal of pharmacology and experimental therapeutics.
[49] C. Mathis,et al. Quantitative in vitro and ex vivo autoradiography of the α2-adrenoceptor antagonist [3H]atopamezole , 1992 .
[50] Á. Pazos,et al. Quantitative light microscopic autoradiographic localization of α 2-adrenoceptors in the human brain , 1992, Brain Research.
[51] J. Zarranz,et al. Decreased Density of Presynaptic α2‐Adrenoceptors in Postmortem Brains of Patients with Alzheimer's Disease , 1992, Journal of neurochemistry.
[52] G. Vauquelin,et al. Regional Distribution of α2A‐and α2B‐Adrenoceptor Subtypes in Postmortem Human Brain , 1992 .
[53] J. García-Sevilla,et al. α 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression , 1992, Biological Psychiatry.
[54] Á. Díaz,et al. Regionally specific age-dependent decline in α 2-adrenoceptors: An autoradiographic study in human brain , 1991, Neuroscience Letters.
[55] G. Vauquelin,et al. Autoradiographic distribution of α 2 adrenoceptors, NAIBS, and 5-HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscine , 1991, Brain Research.
[56] J. Palacios,et al. Autoradiography of adrenoceptors in rat and human brain: alpha-adrenoceptor and idazoxan binding sites. , 1991, Progress in brain research.
[57] Á. Pazos,et al. α2-Adrenoceptors in human forebrain: autoradiographic visualization and biochemical parameters using the agonist [3H]UK-14304 , 1988, Brain Research.
[58] J. Palacios,et al. Distribution of α2-adrenergic receptors in the human brainstem: An autoradiographic study using [3H]p-aminoclonidine , 1984 .
[59] H. Herdon,et al. Diethylstilbestrol regulates the number of α- and β-adrenergic binding sites in incubated hypothalamus and amygdala , 1982, Brain Research.
[60] S. Z. Langer. Presynaptic regulation of the release of catecholamines. , 1980, Pharmacological reviews.
[61] S. Z. Langer. Presynaptic receptors and modulation of neurotransmission: pharmacological implications and therapeutic relevance , 1980, Trends in Neurosciences.
[62] H. Herdon,et al. Radioligand binding studies on hypothalamic noradrenergic receptors during the estrous cycle or after steroid injection in ovariectomized rats , 1979, Brain Research.
[63] E. Talley,et al. Distribution of α2A‐adrenergic receptor‐like immunoreactivity in the rat central nervous system , 2022 .